ConductScience.org, home

Paper422706

Metabolic clearance and plasma half-disappearance time of exogenous somatostatin in man.

Sheppard M and 5 others. J Clin Endocrinol Metab, 1979. Cited by 201 papers, by iCite.

Cite this record

ConductScience Library. Metabolic clearance and plasma half-disappearance time of exogenous somatostatin in man. Papers, record 422706. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/422706

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Metabolic clearance and plasma half-disappearance time of exogenous somatostatin in man.
PubMed
Journal
J Clin Endocrinol Metab
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
201
iCite
Relative citation ratio, by iCite
7.04
iCite
Revised in PubMed
2004-11-17
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sheppard MM
2Shapiro BB
3Pimstone BB
4Kronheim SS
5Berelowitz MM
6Gregory MM

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
SomatostatinMajor topic
Adult
Female
Half-Life
Humans
Kidney Failure, Chronic
Kinetics
Liver Diseases
Male
Metabolic Clearance Rate
Middle Aged

Source PubMed

Download CSV of topics

Cited by43

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 201 citations.

PMIDTitleJournalYearIn PapersSource
42123401Somatostatin and Its Analogues as Second-Line Treatments in Non-Neoplastic Conditions.Int J Mol Sci2026https://conductscience.org/library/papers/42123401PubMed
40542938More Than Three Decades After Discovery of the Neuroprotective Effect of PACAP, What Is Still Preventing Its Clinical Use?J Mol Neurosci2025https://conductscience.org/library/papers/40542938PubMed
38529270From biology to clinical practice: antiproliferative effects of somatostatin analogs in neuroendocrine neoplasms.Ther Adv Med Oncol2024https://conductscience.org/library/papers/38529270PubMed
37692299Vascular-related biomarkers in psychosis: a systematic review and meta-analysis.Front Psychiatry2023https://conductscience.org/library/papers/37692299PubMed
33329885Somatostatin analogues for the treatment of hyperinsulinaemic hypoglycaemia.Ther Adv Endocrinol Metab2020https://conductscience.org/library/papers/33329885PubMed
32887456Overview of Radiolabeled Somatostatin Analogs for Cancer Imaging and Therapy.Molecules2020https://conductscience.org/library/papers/32887456PubMed
29973528Somatostatin Analogue Treatment Primarily Induce miRNA Expression Changes and Up-Regulates Growth Inhibitory miR-7 and miR-148a in Neuroendocrine Cells.Genes (Basel)2018https://conductscience.org/library/papers/29973528PubMed
27399347N-Terminal Prosomatostatin as a Risk Marker for Cardiovascular Disease and Diabetes in a General Population.J Clin Endocrinol Metab2016https://conductscience.org/library/papers/27399347PubMed
27247538Enterocutaneous Fistula: Proven Strategies and Updates.Clin Colon Rectal Surg2016https://conductscience.org/library/papers/27247538PubMed
26884209AAVP displaying octreotide for ligand-directed therapeutic transgene delivery in neuroendocrine tumors of the pancreas.Proc Natl Acad Sci U S A2016https://conductscience.org/library/papers/26884209PubMed
25880900The relationship between N-terminal prosomatostatin, all-cause and cardiovascular mortality in patients with type 2 diabetes mellitus (ZODIAC-35).BMC Endocr Disord2015https://conductscience.org/library/papers/25880900PubMed
24587133Comparative study of somatostatin-human serum albumin fusion proteins and natural somatostatin on receptor binding, internalization and activation.PLoS One2014https://conductscience.org/library/papers/24587133PubMed
24058344Reduced brain somatostatin in mood disorders: a common pathophysiological substrate and drug target?Front Pharmacol2013https://conductscience.org/library/papers/24058344PubMed
23485864Differential pulsatile secretagogue control of GH secretion in healthy men.Am J Physiol Regul Integr Comp Physiol2013https://conductscience.org/library/papers/23485864PubMed
22358499Obstacles on the way to the clinical visualisation of beta cells: looking for the Aeneas of molecular imaging to navigate between Scylla and Charybdis.Diabetologia2012https://conductscience.org/library/papers/22358499PubMed
22345429A somatostatin analog improves tilt table tolerance by decreasing splanchnic vascular conductance.J Appl Physiol (1985)2012https://conductscience.org/library/papers/22345429PubMed
16984213Pharmacokinetic profile of the somatostatin analogue lanreotide in individuals with chronic hepatic insufficiency.Clin Pharmacokinet2006https://conductscience.org/library/papers/16984213PubMed
11878792Pancreatic surgical complications--the case for prophylaxis.Gut2001https://conductscience.org/library/papers/11878792PubMed
11878789Role of somatostatin-14 and its analogues in the management of gastrointestinal fistulae: clinical data.Gut2001https://conductscience.org/library/papers/11878789PubMed
9098878Extensive biliary excretion of the model opioid peptide [D-PEN2,5] enkephalin in rats.Pharm Res1997https://conductscience.org/library/papers/9098878PubMed

See all 43 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
SST6750PubTator's text mininghttps://conductscience.org/library/genes/6750

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/422706

GET https://conductscience.org/api/papers/v1/422706/cited_by?page=2